Diagnostic Test of Choice for HELPS Syndrome

November 3, 2020 updated by: Christopher Honey, University of British Columbia

Microvascular Decompression for HELPS Syndrome: What is the Best Diagnostic Test?

Our team recently described a new medical condition called HELPS (Hemi-Laryngo-Pharyngeal-Spasm) syndrome(1). HELPS syndrome is a condition caused by a blood vessel pinching the nerve rootlets of the Vagus nerve (Xth cranial nerve). It is similar to the well recognized hemifacial spasm syndrome but the nerve involved is the Vagus instead of the Facial nerve. As a result, the symptoms are episodic throat contractions and cough. The throat contractions become stronger and more frequent over the years and can lead to a terrifying inability to breath. Patients may end up intubated in the Emergency Department or with a tracheostomy because of inability to breath during a severe episode. Some but not all of our patients can tell which side of their throat (left or right) contracts during a choking episode. In between these choking episodes, patients feel normal. A surgical cure for these patients is Microvascular Decompression of the Xth nerve.

Study Overview

Detailed Description

The treatment of HELPS syndrome begins with the correct diagnosis. Some patients are able to localize the side of their symptoms in HELPS syndrome while others are unable to. The purpose of this study is to prospectively study which of the following is the diagnostic test of choice for patients who are unable to localize their HELPS: 1. CISS MRI sequences, 2. interictal laryngoscopy, and 3. unilateral and contralateral Botox injections separated 3-months apart.

Both neuroradiologist and otolaryngologist will be blinded to the outcome of surgery and be asked "based on your diagnostic test, which side do you believe we should perform MVD surgery?"

Study Type

Observational

Enrollment (Actual)

6

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Vancouver General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

HELPS (Hemi-Laryngo-Pharyngeal Spasm) Syndrome

-Subgroup of patients who are unable to localize lateralization of throat contractions

Description

Inclusion Criteria:

  • Patients diagnosed with HELPS as described in our initial publication (Honey et al. 2016)
  • Patients unable to localize the side of their HELPS syndrome

Exclusion Criteria:

- Unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
HELPS Syndrome unable to lateralize contractions
Each patient will have the following 3 diagnostic pre-operative tests: i) MRI (CISS sequence), ii) video laryngoscopy, and iii) sequential Botox injections in their throat (left side and then 3 months later on the right side).
Compare pre-operative MRI diagnosis to intra-operative findings on if both are in agreement
Compare pre-operative laryngoscopy diagnosis to intra-operative findings on if both are in agreement
Compare pre-operative diagnosis using Botox to intra-operative findings on if both are in agreement
Other Names:
  • Injections spaced 3-months apart

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pre-Operative CISS MRI (One month before surgery) compared to Intraoperative Findings
Time Frame: Pre-Operative and Intra-Operative
Determine if CISS MRI sequence lateralization in concordance with intraoperative findings
Pre-Operative and Intra-Operative
Pre-Operative Interictal Laryngoscopy (One month before surgery) compared to Intraoperative Findings
Time Frame: Pre-Operative vs. Intra-Operative
Determine if interictal laryngoscopy in concordance with intraoperative findings
Pre-Operative vs. Intra-Operative
Pre-Operative 3 and 6-month Botox Injections compared to Intraoperative Findings
Time Frame: Pre-operative 3 and 6 months vs. Intra-Operative
Determine if unilateral vs contralateral Botox-induced symptom reduction in concordance with intraoperative findings
Pre-operative 3 and 6 months vs. Intra-Operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher R Honey, MD, DPhil, FRCSC, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2017

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

October 30, 2018

Study Registration Dates

First Submitted

April 10, 2017

First Submitted That Met QC Criteria

April 21, 2017

First Posted (Actual)

April 25, 2017

Study Record Updates

Last Update Posted (Actual)

November 5, 2020

Last Update Submitted That Met QC Criteria

November 3, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H17-00953

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HELPS Syndrome

Clinical Trials on Pre-Operative CISS-MRI Sequences

Subscribe